Title
Category
Credits
Event date
Cost
  • S.U.D
$0.00
Enjoy this recording from the July 14th 2021-22 California Residency Program Collaboration (CRPC) Webinar where we listen to Dr. Trotzky-Sirr present her “eight hours in eight minutes” session on Medication Assisted Treatment (MAT) and Buprenorphine prescribing and hear from Sherrie Cisneros, a Substance Use Navigator, about effectively using your team’s resources to improve patient care and finally, we receive a quick overview of the many excellent resources that CA Bridge has to offer.
  • S.U.D
$0.00
Summary This activity is a recording of virtual session offered in March, 2021 through the California Residency Program Collaborative (CRPC) around improving Substance Use Disorder (SUD) services and includes a list of additional resources and a robust Q&A section.  Treating SUD - Linking with Community Services offers information, tools and resources to clinicians considering the addition of Medication Assisted Treatment (MAT) services for their patients.ResourcesResources mentioned during the roundtable discussion:
  • S.U.D
$0.00
Summary This activity is a recording of virtual session offered in March, 2021 through the California Residency Program Collaborative (CRPC) around improving Substance Use Disorder (SUD) services and includes a list of additional resources and a robust Q&A section.  Incorporating MAT into Practice – A Community Conversation offers learners an opportunity to listen in while more experienced MAT providers provide tips and tricks and discuss lessons learned throughout their career providing MAT services.
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objective:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, participants should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objectives:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:

Pages